Haoxi Health Technology Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Haoxi Health Technology Limited on April 23, 2025. The filing serves to furnish exhibits containing the Unaudited Condensed Consolidated Financial Statements and Management's Discussion and Analysis (MD&A) for the six months ended December 31, 2024, and the comparable period in 2023.
Key Financial Metrics
The provided text is a cover page and exhibit index; it does not contain specific financial data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not available in this excerpt. Investors must refer to Exhibit 99.1 for the financial statements and Exhibit 99.2 for the MD&A to obtain these figures.
Material Changes
The filing text does not provide a clear value or description of material changes versus the prior comparable period. Such analysis is contained within the attached MD&A document (Exhibit 99.2).
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed in the cover page text. These disclosures are expected to be found in the attached Management's Discussion and Analysis (Exhibit 99.2).
Investor Verification Checklist
- Verify the specific revenue and net income figures for the six months ended December 31, 2024, in Exhibit 99.1.
- Review the MD&A in Exhibit 99.2 for explanations of any year-over-year performance changes.
- Confirm the company's liquidity position and debt obligations as detailed in the attached financial statements.
- Check for any new risk factors or contingencies disclosed in the MD&A section.